The current treatment landscape for hospitalized patients with COVID-19 has changed dramatically since the early days of the pandemic. More treatment options, supported by key international studies such as the EPIC-HR, RECOVERY, and PINETREE trials, have provided clinicians with important evidence of safety and efficacy as well as treatment timing guidelines.
Early use of antiviral therapy and immunomodulatory medications now represents a vital component of treatment in patients who have been hospitalized due to COVID-19 or who were previously admitted for unrelated conditions and incidentally tested positive.
In this ReCAP, Karine Lacombe, MD, PhD, head of Department of Infectious Diseases at Hospital Saint-Antoine in Paris, France, discusses the specific subpopulations of patients who are most commonly hospitalized with COVID-19 today, and the most effective early treatment approaches on the basis of disease severity, including second-line therapeutic options.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Optimizing COVID-19 Treatment in Hospitalized Patients - Medscape - Dec 02, 2022.
Comments